AML Cell Immunotherapy Using Chimeric Antigen Receptor T-cells
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
- Status
- RECRUITING
- Phase
- PHASE3
D-CTAG in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Elderly Patients
- Status
- UNKNOWN
- Phase
- NA
NTX-301 in MDS/AML
- Status
- COMPLETED
- Phase
- PHASE1
Study in Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Patients to Determine the Recommended Dose of CYAD-02
- Status
- RECRUITING
- Phase
- PHASE1
Muscle Dysfunction in Patients With Hematological Diseases Referred to Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Haploidentical Stem Cell Transplant With or Without NK Cell Infusion in AML and MDS
- Status
- TERMINATED
- Phase
- PHASE2
Integrating Geriatric Assessment for Older Patients Diagnosed With Acute Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- NA
CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
A Study of ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML)
- Status
- TERMINATED
- Phase
- PHASE1
CD34 Selected Allogeneic HCT w/ Myeloablative Conditioning Plus CD8+ Memory TCell Infusion in MDS, AL and CML
- Status
- COMPLETED
- Phase
- PHASE2
A Study of MBG453 in Combination With Azacitidine and Venetoclax in AML Patients Unfit for Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Salsalate, Venetoclax, and Decitabine or Azacitidine for the Treatment of Acute Myeloid Leukemia or Advanced Myelodysplasia/Myeloproliferative Disease
- Status
- COMPLETED
- Phase
- PHASE2
Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Venetoclax and Azacitidine for the Treatment of Acute Myeloid Leukemia in the Post-Transplant Setting
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Clinical Trial to Assess the Efficacy and Safety of the Combination of a Drug Call Quizartinib With Chemotherapy (FLAG-IDA) in Patients With Acute Myeloid Leukemia That Has Not Responded to the First Treatment or That Has Returned After the First Treatment
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Trial to Compare Efficacy and Safety of Chemotherapy/Quizartinib vs Chemotherapy/Placebo in Adults FMS-like Tyrosine Kinase 3 (FLT3) Wild-type Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Ficlatuzumab With HiDAC and HiDAC Alone in Adults With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)
- Status
- TERMINATED
- Phase
- PHASE3